Genetic susceptibility to radiations: Which impact on medical practice?

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 4, 2000, Pages 347-354

  Alapetite, C ^a   Cosset, J M ^a   Bourguignon, M H ^a   Masse, R ^a  

^a INSTITUT CURIE   (France)

Author keywords

Dosimetry; Hereditary diseases; Radiation protection

Indexed keywords

APOPTOSIS; ATAXIA TELANGIECTASIA; BEHCET DISEASE; CANCER; CANCER SUSCEPTIBILITY; CLONOGENIC ASSAY; CYTOGENETICS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSIMETRY; FANCONI ANEMIA; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY; IONIZING RADIATION; MEDICAL PRACTICE; MOLECULAR BIOLOGY; PRACTICE GUIDELINE; PULSED FIELD GEL ELECTROPHORESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOSENSITIVITY; REVIEW; RISK BENEFIT ANALYSIS; SCLERODERMA; SECOND CANCER;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE;

EID: 0034480566     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Genetic susceptibility to radiation effects: Possible implication for medical ionising radiation exposures
2. Genetic susceptibility to cancer
3. Tumor and individual radiosensitivity. An introduction
4. Ataxia telangiectasia: A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent infection
5. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
6. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiations is associated with a repair deficiency of DNA double-strand breaks
7. Responses to DNA damage and regulation of the cell cycle checkpoints by the ATM protein kinase family
8. Heterozygous ATM mutations do not contribute to early onset breast cancer
9. Absence of mutations in the ATM gene in breast cancer patients with severe response to radiotherapy
10. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients
11. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients
12. Absence of ATM truncations in patients with severe acute radiation reactions
13. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effect
14. Radiosensitivity of normal tissues in ataxia telangiectasia heterozygotes
15. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease
16. Assessment of the risk of breast cancer following Hodgkin's disease: The effects of treatment, age at treatment, attained age, ATM heterozygosity, and selection bias
17. Is Fanconi anemia caused by a defect in the processing of DNA damage?
18. Second cancers after treatment for retinoblastoma: Incidence and mortality in long term survivors
19. Cancer predisposition, radiosensitivity and the risk of radioinduced cancers
20. The genetic implications of long term survival of childhood cancer
21. Multiple schwannomas and meningiomas associated with irradiation in childhood
22. Markers of DNA repair and susceptibility to cancer in humans: An epidemiological review
23. Cancer predisposition, radiosensitivity and the risk of cancer induced. Prediction of risks in relatives of cancer-predisposed individuals
24. Double-strand break repair deficiency and radiation sensitivity in BRCA 2 mutant cancer cells
25. Response to radiation therapy and prognosis in breast cancer patients with BRCA2 mutations
26. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
27. Prognosis of BRCA1 hereditary breast cancer
28. Survival in early-onset BRCA1 breast cancer patients. Institut Curie Breast Cancer Group
29. Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancer
30. Cancers detected and induced in mammographic screening: New screening schedules and younger women with family history
31. Benefit versus risks from mammography: A critical re-assessment
32. Increased benefit from shorter screening mammography intervals for women ages 40-49 years
33. Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
34. Irradiation in the setting of collagen vascular disease: Acute and late complications
35. Major interactions between radiation therapy and systemic sclerosis: Is there an optimal treatment?
36. Severe fibrosis in a patient with scleroderma and previous radiotherapy: A case report and literature review
37. Exacerbation of progressive scleroderma following roentgen therapy
38. Delayed repair of DNA damage by ionizing radiation in cells from patients with systemic lupus erythematosus and rheumatoid arthritis
39. Heightened sensitivity of the oesophagus to radiation in a patient with AIDS
40. Bullous skin reactions after soft roentgen radiotherapy of HIV-associated Kaposi sarcoma
41. Severe oesophageal toxicity after thoracic radiation abtherapy for lung cancer associated with the human immunodeficiency virus: A case report and review of the literature
42. Glutathione deficiency and radiosensitivity in AIDS patients
43. Radiosensitivity in AIDS
44. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma
45. Cancer and radiation therapy in Behcet's disease. ECCO conference 10
46. Diabetes mellitus: A predictor for late radiation morbidity
47. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients
48. In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer
49. Fibroblasts radiosensitivity versus acute and late normal skin responses in breast cancer
50. Relationship between the in vitro radiosensitivity of skin fibroblasts and the subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy
51. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer
52. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules
53. Evidence for a positive correlation between in vitro rediosensitivity of normal human skinfibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy
54. Intrinsic radiosensitivity of human fibroblasts seems to be unable to predict normal tissue response to radiotherapy
55. Defective repair of DNA double strand breaks and chomosome damage in fibroblasts from a radiosensitive leukemia patient
56. A correlation between residual radiation-induced double-strand breaks in cultured fibroblast and late radiotherapy reactions in breast cancer patients
57. Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patient
58. Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy: A preliminary study
59. Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: Defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients
60. Gamma induced single cell DNA damage as a measure of susceptibility to lung cancer: A preliminary report
61. Comet assay as a tool for mouse models with inherited radiation sensitivity
62. Deregulated apoptosis in ataxia telangiectasia: Association with clinical stigmata and radiosensitivity
63. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes
64. Profils apoptotiques altérés chez les patients irradiés montrant une hypersensibilité
65. Unexpected tumor response, radiation myelitis and increased in vitro radio-sensitivity of lymphocytes in a patient with a non-small lung cancer
66. The prediction of human tumor radiosensitivity in situ: An approach using chromosome aberrations detected by fluorescence in situ hybridization
67. The impact of complex chromosomal rearrangements on the detection of cancer patients
68. Induced micronucleus in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families
69. Comparison of normal tissue cells with normal tissue reactions after radiotherapy
70. Rare microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity
71. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy
72. Prediction of normal-tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity
73. Radiosensitivity testing of normal tissues: A way to optimize radiotherapy
74. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity
75. Potential clinical impact of normal tissue intrinsic radiosensitivity testing
76. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing
77. BRCA1 protein products... Functional motifs
78. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood